Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check7 days agoChange DetectedA new line '2018 ( U.S. NIH Grant/Contract )' was added under the Other Study ID Numbers, indicating NIH grant support for the study.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor site update without altering the clinical trial information presented.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.6.3 has been added, replacing v3.6.2, representing a minor backend/page update without affecting study content.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page's revision label changes from v3.6.0 to v3.6.2, signaling a newer edition of the page's metadata.SummaryDifference0.1%

- Check79 days agoChange DetectedRecruitment status changed to 'No longer looking for participants,' and new help sections such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study' were added. The page also updates the Intervention/Treatment heading formatting and the revision note to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.